1.Supratentorial Hemangioblastoma with Unusual Features.
Yooju SHIN ; Seokhwi KIM ; Hyun Woo LEE ; Heejin BANG ; Yeon Lim SUH
Korean Journal of Pathology 2014;48(6):462-465
No abstract available.
Hemangioblastoma*
2.Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute.
Yooju SHIN ; Sang Yun HA ; Jiyeon HYEON ; Boram LEE ; Jeeyun LEE ; Kee Taek JANG ; Kyoung Mee KIM ; Young Suk PARK ; Cheol Keun PARK
Cancer Research and Treatment 2015;47(4):738-746
PURPOSE: Management of gastroenteropancreatic (GEP) neuroendocrine tumors with liver metastases (NETLM) presents many clinical challenges. Assessment of the extent of disease and primary tumor site is crucial for management. In this study, we investigated the primary tumor sites and prognostic factors in GEP NETLM among Korean patients. MATERIALS AND METHODS: We reviewed the medical records of 72 Korean patients diagnosed with GEP NETLM between January 1999 and May 2013, focusing on their clinical and pathologic characteristics. RESULTS: The most frequently encountered primary tumor sites were the pancreas (n=25, 35%), stomach (n=8, 11%), gall bladder (n=4, 6%) and rectum (n=3, 4%). Twenty-five patients (35%) had occult primary tumor. Twelve patients (17%) had histological grade G1 tumors, 30 patients (42%) had G2 tumors, and 30 patients (42%) had G3 tumors. The mean follow-up period after histological confirmation of hepatic metastases was 11.30+/-2.44 months for G3 tumors, 19.67+/-4.09 months for G2 tumors, and 30.67+/-6.51 months for G1 tumors. Multivariate analyses revealed that an unknown primary tumor site (p=0.001) and higher histological grade (p < 0.001) were independent prognostic indicators for shorter overall survival (OS). Most long-term survivors (OS > 24 months) had received antitumor treatment. CONCLUSION: The primary tumor site most frequently associated with GEP NETLM was the pancreas. Unknown primary tumor and higher histological grade were independent prognostic indicators for shorter OS. Patients identified as being at a risk of shorter OS should be followed up closely.
Follow-Up Studies
;
Humans
;
Korea*
;
Liver*
;
Medical Records
;
Multivariate Analysis
;
Neoplasm Metastasis*
;
Neoplasms, Unknown Primary
;
Neuroendocrine Tumors*
;
Pancreas
;
Pathology
;
Prognosis
;
Rectum
;
Stomach
;
Survivors
;
Urinary Bladder
3.Placental Mesenchymal Dysplasia with Fetal Gastroschisis.
Binnari KIM ; Jiyeon HYEON ; Minju LEE ; Hyewon HWANG ; Yooju SHIN ; Suk Joo CHOI ; Jung Sun KIM
Journal of Pathology and Translational Medicine 2015;49(1):71-74
No abstract available.
Gastroschisis*
4.PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors.
Yooju SHIN ; Jiyeon HYEON ; Boram LEE ; Sang Yun HA ; Min Eui HONG ; In Gu DO ; Kyoung Mee KIM
Journal of Pathology and Translational Medicine 2015;49(1):23-29
BACKGROUND: Counting mitoses is subjective and time-consuming. The adjunctive diagnostic utility of a recently reported mitotic marker, phosphohistone H3 (PHH3), was investigated in gastrointestinal stromal tumors (GISTs). METHODS: We reviewed 77 GISTs for several proliferative indices. These included the mitotic count per 50 high power fields (HPFs), the immunohistochemical Ki-67 labeling index and the immunohistochemical PHH3 mitotic index (MI). For comparison, Spearman's rank correlation and interclass correlation coefficient were used. RESULTS: Mitotic counts ranged from 0-138 (mean, 7.57+/-2.34) and the PHH3 MI ranged from 0-126 per 50 HPFs (mean, 9.61+/-2.27). We found a positive correlation between mitotic counts and PHH3 MI (r=0.810, p<.001). The inter-observer correlation coefficient for three participants was 0.975 for mitotic counts and 0.940 for the PHH3 MI. When using the PHH3 MI instead of mitotic counts in the Armed Forces Institute of Pathology (AFIP) stratification criteria, 10 cases were reclassified. In one patient with a mitotic count of 2 and a PHH3 MI of 6 per 50 HPFs, distant metastasis occurred. CONCLUSIONS: In GISTs, the PHH3 MI correlated adequately with mitotic counts and can be used as a useful adjunctive to count mitotic figures efficiently.
Arm
;
Biomarkers
;
Gastrointestinal Stromal Tumors*
;
Humans
;
Mitosis
;
Mitotic Index
;
Neoplasm Metastasis
;
Pathology
5.Retention Esophagitis as a Significant Clinical Predictor of Progression to Esophageal Cancer in Achalasia.
Haewon KIM ; Hyojin PARK ; HeeSeung CHOI ; Yooju SHIN ; Hyunsung PARK ; Young Hoon YOUN ; Jie Hyun KIM
Clinical Endoscopy 2018;51(2):161-166
BACKGROUND/AIMS: Chronic liquid and/or food stasis caused by retention esophagitis (RE) in achalasia is a notable endoscopic finding because of the presence of a thickened or whitish esophageal mucosa and histologically altered squamous hyperplasia. We aimed to identify the clinical features of RE associated with achalasia and to clarify the clinical definition of RE in achalasia as a precancerous lesion identified by analyzing biomarker expressions. METHODS: From 2006 to 2015, we retrospectively reviewed 37 patients with achalasia without previous treatment. Among them, 21 patients had diagnostic findings of RE (RE+) and 16 patients had no diagnostic findings of RE (RE−). Immunohistochemical staining of p53, p16, and Ki-67 was performed on the endoscopic biopsy tissues from the patients with achalasia and 10 control patients with non-obstructive dysphagia. RESULTS: The symptom duration and transit delay were significantly longer in the RE+ group than in the RE− group. We found particularly high p53 positivity rates in the RE+ group (p<0.001). The rate of p16 expression was also significantly higher in the RE+ group than in the other two groups (p=0.003). CONCLUSIONS: A high p53 expression rate was more frequently found in the RE+ group than in the other two groups. RE could be a meaningful clinical feature of achalasia for predicting esophageal carcinogenesis.
Biopsy
;
Carcinogenesis
;
Deglutition Disorders
;
Esophageal Achalasia*
;
Esophageal Neoplasms*
;
Esophagitis*
;
Humans
;
Hyperplasia
;
Mucous Membrane
;
Retrospective Studies
;
Tumor Suppressor Protein p53
6.Incidence of Acute Kidney Injury after Adrenalectomy in Patients with Primary Aldosteronism
Jee Young LEE ; Hyoungnae KIM ; Hyung Woo KIM ; Geun Woo RYU ; Yooju NAM ; Seonyeong LEE ; Young Su JOO ; Sangmi LEE ; Jung Tak PARK ; Seung Hyeok HAN ; Shin Wook KANG ; Tae Hyun YOO ; Hae Ryong YUN
Electrolytes & Blood Pressure 2019;17(2):45-53
BACKGROUND:
Aldosterone-induced glomerular hyperfiltration can lead to masked preoperative renal dysfunction in primary aldosteronism(PA) patients. We evaluated whether PA patients had a higher prevalence of acute kidney injury (AKI) after unilateral adrenalectomy. In addition, we identified risk factors for AKI in these subjects.
METHODS:
This retrospective study included 107 PA patients, and 186 pheochromocytoma patients as a control group, all of whom underwent adrenalectomy between January 2006 and November 2017 at Yonsei University Severance Hospital. The primary outcome was AKI within 48 hours after adrenalectomy. Univariate and multivariate logistic regression analyses were performed to identify predictors of AKI after adrenalectomy.
RESULTS:
Overall incidence of AKI was 49/293 (16.7%). In PA patients, the incidence of AKI was 29/107 (27.1%). In contrast, incidence of AKI was 20/186 (10.7%) in pheochromocytoma patients. Univariate and multivariate logistic regression analysis both showed a higher risk of postoperative AKI in PA patients compared to pheochromocytoma patients. In addition, old age, diabetes, longer duration of hypertension, lower preoperative estimated glomerular filtration rate, high aldosterone-cortisol ratio (ACR) and lateralization index (LI) were identified as independent risk factors for postoperative AKI in PA patients after unilateral adrenalectomy.
CONCLUSION
Incidence and risk of postoperative AKI were significantly higher in PA patients after surgical treatment. High ACR on the tumor side and high LI were associated with higher risk of AKI in PA patients compared to pheochromocytoma patients.
7.Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants
Yong Chan KIM ; Bongyoung KIM ; Nak-Hoon SON ; Namwoo HEO ; Yooju NAM ; Areum SHIN ; Andrew Jihoon YANG ; Min Hyung KIM ; Taeyoung KYONG ; Eawha KANG ; Yoon Soo PARK ; Heejung KIM
Journal of Korean Medical Science 2023;38(1):e9-
Background:
We evaluated the household secondary attack rate (SAR) of the omicron and delta severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, according to the vaccination status of the index case and household contacts; further, in vaccinated index cases, we evaluated the effect of the antibody levels on household transmission.
Methods:
A prospective cross-sectional study of 92 index cases and 197 quarantined household contacts was performed. Tests for SARS-CoV-2 variant type and antibody level were conducted in index cases, and results of polymerase chain reaction tests (during the quarantine period) were collected from contacts. Association of antibody levels in vaccinated index cases and SAR was evaluated by multivariate regression analysis.
Results:
The SAR was higher in households exposed to omicron variant (42%) than in those exposed to delta variant (27%) (P = 0.040). SAR was 35% and 23% for unvaccinated and vaccinated delta variant exposed contacts, respectively. SAR was 44% and 41% for unvaccinated and vaccinated omicron exposed contacts, respectively. Booster dose immunisation of contacts or vaccination of index cases reduced SAR of vaccinated omicron variant exposed contacts. In a model with adjustment, anti-receptor-binding domain antibody levels in vaccinated index cases were inversely correlated with household transmission of both delta and omicron variants.Neutralising antibody levels had a similar relationship.
Conclusion
Immunisation of household members may help to mitigate the current pandemic.